Category: Business Idea

(Bloomberg) — The Robinhood generation of day traders has famously driven scores of sharp stock moves this year, from high-flyers like Tesla Inc. to beaten-down companies such as Hertz Global Holdings Inc. Now, retail investors are propelling growth in a …

(Bloomberg) — Natural gas producer Gulfport Energy Corp. filed for bankruptcy, joining a slew of U.S. energy companies that are collapsing after the global pandemic deepened their struggle with low prices and too much debt.The Oklahoma City-based driller filed a …

(Bloomberg) — The stakes are high for the results of Moderna Inc.’s coming Covid-19 vaccine trial. But as far as investors are concerned, the impact may already be in the price of financial assets.The bar was raised for markets to …

(Bloomberg Opinion) — After five states — Arizona, Mississippi, Montana, New Jersey and South Dakota — passed ballot measures for marijuana use last week, the drug will soon be legal in some form for 70% of the U.S. population. A …

(Bloomberg) — China’s clampdown on internet and fintech giants has pummeled shares of Alibaba Group Holding Ltd., erasing $165 billion of market value and prompting some investors to reassess their holdings.After a 19% plunge from record highs at the end …

Chinese electric car manufacturer NIO Limited (NIO) just may be one of the hottest stocks in an already overheated stock market. In the past 52 weeks alone, NIO stock has gained 2,138%, and according to J.P. Morgan analyst Nick Lai, …

(Bloomberg) — Biogen Inc. shares plunged on Monday and analysts braced for further declines after a U.S. Food and Drug Administration advisory panel harshly judged the efficacy of the company’s experimental Alzheimer’s disease therapy, dimming prospects it will be approved …

(Bloomberg) — Stock markets in the Middle East, the first to trade after Joe Biden’s victory in the U.S. election, are signaling bets the new president will reduce international conflict and push for peace in the region.That optimism outweighed concern …

The votes have been counted, and a decision has been rendered — no, not on the winner of the U.S. Presidential election (unfortunately), but on Biogen's (BIIB) aducanumab Alzheimer’s drug.By a vote of one for, eight against, and two abstaining, …